According to GuruFocus’ list, these stocks have reached their 52-week lows.
CVS reached the 52-week low of $89.44
The price of CVS Health Corp. (CVS, Financial) shares has declined to close to the 52-week low of $89.44 per share, which is 18.9% off the 52-week high of $106.67. The company has a market cap of $95.36 billion.
Its shares traded at $89.44 per share as of Sept. 14 with a price-earnings (P/E) ratio of 20.58 and a price-sales (P/S) ratio of 0.61. CVS' trailing 12-month dividend yield is 1.82%. The forward dividend yield is 1.87%. The company had an annual average earnings growth of 11.50% over the past 10 years. GuruFocus rated CVS’ business predictability at 5 stars.
CVS is an integrated pharmacy health care provider. It has three segments: Pharmacy Services, Retail Pharmacy and Corporate.
Net revenue for the three months ended June 30 increased 17.6%, or $6.6 billion, to $43.7 billion, compared to the three months ended June 30, 2015.
Bristol-Myers Squibb reached the 52-week low of $55.23
The price of Bristol-Myers Squibb Company (BMY, Financial) shares has declined to close to the 52-week low of $55.23 per share, which is 28.7% off the 52-week high of $77.12. The company has a market cap of $92.28 billion.
Its shares traded at $55.23 as of Sept. 14 with a P/E ratio of 32.30 and a P/S ratio of 5.26. Bristol-Myers' trailing 12-month dividend yield is 2.74%. The forward dividend yield is 2.73%.
Bristol-Myers is a biopharmaceutical company. It discovers, develops, licenses, manufactures, markets, distributes and sells biopharmaceutical products.
Second-quarter revenue was $4.9 billion, an increase of 17% compared to the same period a year ago.
Director Lamberto Andreotti sold 23,200 shares at a price of $59.17 per share on Aug. 25 and sold 21,600 shares for $56.87 per share on Sept. 8. The price of the stock has decreased by 2.88% since.
Cigna reached the 52-week low of $126.25
The price of Cigna Corp. (CI, Financial) shares has declined to close to the 52-week low of $126.25 per share, which is 18.2% off the 52-week high of $148.99. The company has a market cap of $32.39 billion.
Its shares traded at $126.25 per share as of Sept. 14 with a P/E ratio of 16.38 and a P/S ratio of 0.84. Cigna's trailing 12-month dividend yield is 0.03%. The forward dividend yield is 0.03%. The company had an annual average earnings growth of 14.20% over the past 10 years. GuruFocus rated Cigna’s business predictability at 3.5 stars.
Cigna is a health services organization with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services.
Total revenue for the three months ended June 30 were $9.96 million compared to $9.492 million from the second quarter of 2015.
Vice President and Chief Accounting Officer Mary T. Hoeltzel sold 500 shares for $132.28 per share on Aug. 17. The price of the stock has decreased by 4.56% since.
Kroger reached the 52-week low of $30.71
The price of The Kroger Co. (KR, Financial) shares has declined to close to the 52-week low of $30.71 per share, which is 28.8% off the 52-week high of $42.75. The company has a market cap of $29.14 billion.
Its shares traded at $30.71 per share as of Sept. 14 with a P/E ratio of 14.56 and a P/S ratio of 0.27. Kroger's trailing 12-month dividend yield is 1.41%. The forward dividend yield is 1.55%. The company had an annual average earnings growth of 11.60% over the past 10 years. GuruFocus rated Kroger’s business predictability at 2.5 stars.
Kroger operates retail food and drug stores, multidepartment stores, jewelry stores and convenience stores throughout the U.S. It also manufactures and processes some of the food for sale in its supermarkets.
Net earnings for the second quarter were $383 million. Total sales increased 4.0% to $26.6 billion in the second quarter compared to $25.5 billion for the same period last year.
Cardinal Health reached the 52-week low of $75.26
The price of Cardinal Health Inc. (CAH, Financial) shares has declined to close to the 52-week low of $75.26 per share, which is 19.7% off the 52-week high of $91.23. The company has a market cap of $23.98 billion.
Its shares traded at $75.26 per share as of Sept. 14Â with a P/E ratio of 17.42 and a P/S ratio of 0.21. Cardinal's trailing 12-month dividend yield is 2.14%. The forward dividend yield is 2.30%. The company had an annual average earnings growth of 5.50% over the past 10 years.
Cardinal is a health care services company. It provides pharmaceutical and medical products and services that help pharmacies, hospitals and other health care providers focus on patient care. It also provides medical products to patients in the home.
The company’s fourth-quarter fiscal year revenues were $31.4 billion, an increase of 14% from the fourth quarter last year, and fiscal 2016 revenues were $121.5 billion, an increase of 19% from the same period last year.
CEO, Pharmaceutical Segment Jon L. Giacomin sold 47,251 shares for $82.77 per share on Aug. 16. The price of the stock has decreased by 9.07% since.
SVP and Chief Accounting Officer Stuart G. Laws sold 9,703 shares for $82.45 per share on Aug. 18. The price of the stock has decreased by 8.72% since.
Chief Information Officer Patricia Morrison sold 43,959 shares for $82.5 per share on Aug. 18. The price of the stock has decreased by 8.78% since.
Equity Residential reached the 52-week low of $63.61
The price of Equity Residential (EQR, Financial) shares has declined to close to the 52-week low of $63.61 per share, which is 24.3% off the 52-week high of $82.39. The company has a market cap of $23.25 billion.
Its shares traded at $63.61 per share as of Sept. 14 with a P/E ratio of 5.55 and a P/S ratio of 9.29. Equity Residential's trailing 12-month dividend yield is 3.33%. The forward dividend yield is 3.21%. Equity Residential had an annual average earnings growth of 4.00% over the past 10 years.
Equity Residential is a real estate investment trust engaged in the acquisition, development and management of apartment properties in the U.S. It owns and manages 400 properties located in Boston, New York, Washington, D.C., and South Florida among others.
Total revenue for the second quarter was $595 million compared to $679 million from the year prior.
Start a free seven-day trial of Premium Membership to GuruFocus.
